Our custom-developed research methods help us uncover deeper, more meaningful insights into the many issues driving healthcare today.
We are intensely focused on the efficacy of new medical technologies and services, seeking to anticipate how these advancements can help drive change through the healthcare system as a whole.
In our pursuit to advancing healthcare, we are guided by the following core values:
The pursuit of objective and
Commitment to excellence
Precision and accuracy
Clinical development evaluation
Pricing and reimbursement
Product and services performance
We employ a range of research methods specially built to provide us with objective, scientifically grounded primary market intelligence.
We survey, interview and consult with thousands of professionals each year, in our efforts to understand and track today's most complex healthcare issues.
Healthcare associations and institutes
Academic thought leaders
Healthcare providers and administrators
Regulatory, commercialization and reimbursement experts.
Article: Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists
Article: The Prevalence of Peyronie’s Disease in the United States: A Population-Based Study
Deerfield Advances Healthcare Through the Publication of Novel Findings
Article: Treating Clostridium difficile infections: Should fecal microbiota
transplantation be reclassified from investigational drug to human tissue?
Article: A Global Perspective on Assisted
Reproductive Technology Fertility Treatment: an 8-Country Fertility Specialist Survey
Abstract:The association between obesity and obstructive sleep apnea among males aged 20 years and older in the United States.
Abstract: Calculating the prevalence of urea cycle disorders in the EU5 using an incidence-survival model
Abstract: Modeling the burden of abdominal aortic aneurysm (AAA) in the United States in 2013
Abstract: Modeling the burden of abdominal aortic aneurysm (AAA) in Europe in 2013 **Poster Finalist Award recipient**
Abstract: Forecasting the prevalence of status epilepticus and its subtypes in Europe, 2015-2024
Abstract: Forecasting the prevalence of status epilepticus and its subtypes in the United States, 2015-2024
Deerfield and EuropaBio Report on Regulatory and HTA Scientific Advice for Small and Medium Enterprises
Improving Pharmaceutical Innovation by Building a More Comprehensive Database on Drug Development and Use (Health Affair: Feb 2015)